Navigation Links
Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against Dr. Yamanaka for Deception
Date:5/15/2013

search on the life science forefront. However, Dr. Xu believes that Dr. Yamanaka has steered these professionals down the wrong path. For example, Dr. Xu believes that even the US government was misled into Dr. Yamanaka's hype when the 2008 state of the union address mentioned favoring a way to reprogram adult skin cells to act like embryonic stem cells, as claimed by Dr. Yamanaka. Dr. Xu believes hundreds of millions in taxpayers' money has been wasted in funding such false science.

The Nobel Assembly granted Dr. Yamanaka the Prize in Physiology or Medicine in 2012, acclaiming his artificially transgenic cells created human regenerative potential. Considering the foreseeable consequences threatening human lives, Dr. Xu is working to stop such deception through the legal process.

Dr. Yamanaka labeled his artificial cell produced by oncogene transferring as "somatic cell induction into pluripotent stem cells", i.e. he claimed his artificially transgenic cell study in the name of the plaintiff's patented technology and called it iPSC in short, which was quickly endorsed and followed by a group of prestigious scientists expecting to solve the ethic issue of embryonic stem cell study.

This term used by Dr. Yamanaka is the core of Dr. Xu's patents, including US Patent 6991813 and Dr. Xu alleges that Dr. Yamanaka's study actually has nothing to do with stem cell. Dr. Yamanaka admitted in his article published in Cell Stem Cell magazine in 2012 that he didn't obtain natural pluripotent stem cells by somatic cell induction. According to Dr. Xu, it is critical to ask why such a ridiculous scientific scam has been prevailing worldwide for the past few years.

Human somatic cell induction into pluripotent stem cell is the core content of the Dr. Xu's patented scientific route of "regeneration of damaged organs" and has been accomplished in clinical app
'/>"/>

SOURCE Mebo International; Ardent Law Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
2. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
3. Enbrel® (etanercept) Patent Issued
4. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
5. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
6. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
7. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
8. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
9. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Telomere ... of their Nutraceutical "TELO-20 for Dogs" with ... Telomere-lengthening supplement in the world for dogs. Telomeres ... every chromosome in the body. A wealth of ... experts in Telomere Science and Aging, including Nobel ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that the ... and Mexico currently faces ... approved agents, the anticipated label extension of Boehringer ... of emerging biologics will substantially increase the competitiveness ... IL-5 inhibitors will introduce a new dynamic to the ...
(Date:8/21/2014)... YORK , Aug. 21, 2014 ... congratulates Immune Pharmaceuticals Inc., a biotechnology company, on ... Market.  Immune previously traded on OTCQX®, the best ... by OTC Markets Group. Logo - ... Pharmaceuticals on the successful execution of its growth ...
(Date:8/21/2014)... MOUNTAIN VIEW, Calif. , Aug. 21, 2014 ... their properties and behaviors based on external stimuli ... is poised to have a disruptive effect in ... will revolutionize the business landscape by printing objects ... the aerospace and automotive sectors. Logo ...
Breaking Biology Technology:Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4
... , WALTHAM, Mass., Dec. 14 Decision ... pharmaceutical and healthcare issues, finds that, owing to the launches of ... than sevenfold from $790 million in 2008 to $6.1 billion in ... Kingdom and Japan. , The new Pharmacor report entitled Atrial ...
... , , ROCKVILLE, Md., Dec. 11 ... receipt of $1.7 million in royalty revenue from sales of ... of $3.3 million. In addition, the Company anticipates a ... The difference in estimated and actual revenues for the ...
... explanation for differences in the severity of mental illness in males. ... the handicap. The genetic defect is situated on the X-chromosome; and ... the GDI1 gene that is responsible. The results are being published ... the result of work by the group of Guy Froyen connected ...
Cached Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2Amount of gene surplus determines severity of mental retardation in males 2
(Date:8/22/2014)... Calif. Thomson Reuters , a leading source ... researchers at the University of California, Riverside in its ... minds of our times." , To generate the list, ... to identify researchers whose published work has had enormous ... among some 3,200 individuals who published the greatest number ...
(Date:8/22/2014)... Jolla, CA Research presented at the 29th ... being developed by Hera Therapeutics Inc. combats three ... cause 70 percent of all cervical cancer. , ... HTI-1968 blocked the replication of HPV-16, HPV-18 and ... and Thomas Broker, Ph.D., who presented the findings ...
(Date:8/22/2014)... news release is available in French . ... drain of essential nutrients from African soils looming as a ... report released today finds that over the last five years, ... practices that have rejuvenated 1.6 million hectares and helped them ... the Alliance for a Green Revolution in Africa (AGRA) focuses ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 2Effort to confront Africa's soil health crisis helps millions of farmers triple yields 3Effort to confront Africa's soil health crisis helps millions of farmers triple yields 4
... U.S. Department of Energy,s National Renewable Energy Laboratory (NREL) are ... 1982, NREL has won 52 R&D 100 Awards known ... Innovation" for its groundbreaking work. When it came ... computing (HPC) data center, the NREL team knew it would ...
... family Braconidae are known for their deadly reproductive ... eggs developing in other insects and their larvae, eventually killing ... causing its sterility. Three new species of the parasitoid wasp ... Journal of Hymenoptera Research , reflect this fatal behavior. ...
... A compact, self-contained sensor recorded and transmitted brain activity data ... tests, according to a study funded by the National Institutes ... of brain activity in moving subjects, this implantable device represents ... that move with the power of thought. The report is ...
Cached Biology News:New ultra-efficient HPC data center debuts 2New ultra-efficient HPC data center debuts 3New ultra-efficient HPC data center debuts 4New ultra-efficient HPC data center debuts 5New ultra-efficient HPC data center debuts 6New ultra-efficient HPC data center debuts 7Kill Bill character inspires the name of a new parasitoid wasp species 2Wireless, implanted sensor broadens range of brain research 2Wireless, implanted sensor broadens range of brain research 3
... Abpromise for all tested applications). ... from within residues 2000 to the C-terminus ... acid sequence is proprietary) ... Entrez GeneID: 57697 ...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products: